Remote Monitoring of Civil Infrastructure Based on TomoSAR

Structural health monitoring and damage detection tools are extremely important topics nowadays with the civil infrastructure aging and deteriorating problems observed in urban areas. These tasks can be done by visual inspection and by using traditional in situ methods, such as leveling or using traditional mechanical and electrical sensors, but these approaches are costly, labor-intensive and cannot be performed with a high temporal frequency. In recent years, remote sensing has proved to be a very promising methodology in evaluating the health of a structure by assessing its deformation and thermal dilation. The satellite-based Synthetic Aperture Radar Tomography (TomoSAR) technique, based on the exploitation of a stack of multi-temporal SAR images, allows to remotely sense the movement and the thermal dilation of individual structures with a centimeter-to millimeter-level accuracy, thanks to new generation high-resolution satellite-borne sensors. In this paper, the effectiveness of a recently developed TomoSAR technique in assessing both possible deformations and the thermal dilation evolution of man-made structures is shown. The results obtained using X-band SAR data in two case studies, concerning two urban structures in the city of Naples (Italy), are presented

Performance Improvement for SAR Tomography Based on Local Plane Model

Multilook approaches have been applied in synthetic aperture radar (SAR) tomography (TomoSAR), for improving the density and regularity of persistent scatterers reconstructed from multipass SAR images in both rural and urban regions. Multilook operations assume that all scatterers in a given neighborhood are similar in height, thereby providing additional data for recovering the position and reflectivity of a single scatterer, so that a higher signal-to-noise ratio can be achieved. This is equivalent to assuming that scatterers belonging to a local neighborhood of range-azimuth cells are located on horizontal planes. The present article generalizes this approach by adopting the so-called local plane (LP) model for TomoSAR imaging in urban areas, accounting for local variations in the height of scatterers that are not negligible. Furthermore, an LP-generalized likelihood ratio test (LP-GLRT) algorithm is developed to implement the previous idea. Compared with the multilook generalized likelihood ratio test algorithm, LP-GLRT shows better performance in the case of urban structures and terrains in experiments based on both simulated data and TerraSAR-X images

URBAN MONITORING BASED ON SENTINEL-1 DATA USING PERMANENT SCATTERER INTERFEROMETRY AND SAR TOMOGRAPHY

A lot of research and development has been devoted to the exploitation of satellite SAR images for deformation measurement and monitoring purposes since Differential Interferometric Synthetic Apertura Radar (InSAR) was first described in 1989. In this work, we consider two main classes of advanced DInSAR techniques: Persistent Scatterer Interferometry and Tomographic SAR. Both techniques make use of multiple SAR images acquired over the same site and advanced procedures to separate the deformation component from the other phase components, such as the residual topographic component, the atmospheric component, the thermal expansion component and the phase noise. TomoSAR offers the advantage of detecting either single scatterers presenting stable proprieties over time (Persistent Scatterers) and multiple scatterers interfering within the same range-azimuth resolution cell, a significant improvement for urban areas monitoring. This paper addresses a preliminary inter-comparison of the results of both techniques, for a test site located in the metropolitan area of Barcelona (Spain), where interferometric Sentinel-1 data were analysed

Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT

Some antihypertensive drugs have also renoprotective and anti-inflammatory properties that go beyond their effect on blood pressure. It has been suggested that microalbuminuria and glomerular filtration rate (GFR) are associated with circulating levels of the soluble form of the receptor, sRAGE (soluble receptor for advanced glycation ends-products). In the present analysis, we used data from the TALENT study to evaluate soluble receptor for advanced glycation end-products (sRAGE) plasma levels in patients with hypertension and high-cardiovascular risk-treated nifedipine and telmisartan in combination. Treatment with nifedipine-telmisartan significantly decreased mean systolic and diastolic ambulatory blood pressure and resulted in a significant increase in sRAGE plasma concentrations after 24 weeks of therapy. We concluded that in hypertensive patients with early-stage renal disease, sRAGE concentrations are not influenced by either microalbuminuria or GFR. Long-term treatment with a combination of nifedipine-telmisartan may have a beneficial effect increasing sRAGE plasma levels, thus exerting an atheroprotective and anti-inflammatory activity

Aspects of the planetary Birkhoff normal form

The discovery in [G. Pinzari. PhD thesis. Univ. Roma Tre. 2009], [L. Chierchia and G. Pinzari, Invent. Math. 2011] of the Birkhoff normal form for the planetary many--body problem opened new insights and hopes for the comprehension of the dynamics of this problem. Remarkably, it allowed to give a {\sl direct} proof of the celebrated Arnold's Theorem [V. I. Arnold. Uspehi Math. Nauk. 1963] on the stability of planetary motions. In this paper, using a "ad hoc" set of symplectic variables, we develop an asymptotic formula for this normal form that may turn to be useful in applications. As an example, we provide two very simple applications to the three-body problem: we prove a conjecture by [V. I. Arnold. cit] on the "Kolmogorov set"of this problem and, using Nehoro{\v{s}}ev Theory [Nehoro{\v{s}}ev. Uspehi Math. Nauk. 1977], we prove, in the planar case, stability of all planetary actions over exponentially-long times, provided mean--motion resonances are excluded. We also briefly discuss perspectives and problems for full generalization of the results in the paper.Comment: 44 pages. Keywords: Averaging Theory, Birkhoff normal form, Nehoro{\v{s}}ev Theory, Planetary many--body problem, Arnold's Theorem on the stability of planetary motions, Properly--degenerate kam Theory, steepness. Revised version, including Reviewer's comments. Typos correcte

Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

Background: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings remain uncertain. Methods: This prospective multicenter observational study aimed to estimate the rates of ischemic and bleeding events and their determinants in the follow-up of consecutive patients with atrial fibrillation who suffered an acute cerebrovascular ischemic event while on nonvitamin K antagonist oral anticoagulant treatment. Afterwards, we compared the estimated risks of ischemic and bleeding events between the patients in whom anticoagulant therapy was changed to those who continued the original treatment. Results: After a mean follow-up time of 15.0±10.9 months, 192 out of 1240 patients (15.5%) had 207 ischemic or bleeding events corresponding to an annual rate of 13.4%. Among the events, 111 were ischemic strokes, 15 systemic embolisms, 24 intracranial bleedings, and 57 major extracranial bleedings. Predictive factors of recurrent ischemic events (strokes and systemic embolisms) included CHA2DS2-VASc score after the index event (odds ratio [OR], 1.2 [95% CI, 1.0–1.3] for each point increase; P=0.05) and hypertension (OR, 2.3 [95% CI, 1.0–5.1]; P=0.04). Predictive factors of bleeding events (intracranial and major extracranial bleedings) included age (OR, 1.1 [95% CI, 1.0–1.2] for each year increase; P=0.002), history of major bleeding (OR, 6.9 [95% CI, 3.4–14.2]; P=0.0001) and the concomitant administration of an antiplatelet agent (OR, 2.8 [95% CI, 1.4–5.5]; P=0.003). Rates of ischemic and bleeding events were no different in patients who changed or not changed the original nonvitamin K antagonist oral anticoagulants treatment (OR, 1.2 [95% CI, 0.8–1.7]). Conclusions: Patients suffering a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are at high risk of recurrent ischemic stroke and bleeding. In these patients, further research is needed to improve secondary prevention by investigating the mechanisms of recurrent ischemic stroke and bleeding

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

\ua9 2023, Springer Nature Limited. The Global Parkinson’s Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic and clinical data for use in large-scale analyses to dramatically expand our understanding of the genetic architecture of PD. This report details the workflow for cohort integration into the complex arm of GP2, and together with our outline of the monogenic hub in a companion paper, provides a generalizable blueprint for establishing large scale collaborative research consortia

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

\ua9 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Although over 90 independent risk variants have been identified for Parkinson’s disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis of Parkinson’s disease with 49,049 cases, 18,785 proxy cases and 2,458,063 controls including individuals of European, East Asian, Latin American and African ancestry. In a meta-analysis, we identified 78 independent genome-wide significant loci, including 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) and fine-mapped 6 putative causal variants at 6 known PD loci. By combining our results with publicly available eQTL data, we identified 25 putative risk genes in these novel loci whose expression is associated with PD risk. This work lays the groundwork for future efforts aimed at identifying PD loci in non-European populations